Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Mednax fielding takeover interest from buyout firms: sources

Published 12/01/2017, 01:40 PM
Updated 12/01/2017, 01:40 PM
© Reuters.  Mednax fielding takeover interest from buyout firms: sources

By Carl O'Donnell and Liana B. Baker

(Reuters) - Mednax Inc, a U.S. healthcare network operator targeted by activist hedge fund Elliott Management Corp, is fielding acquisition interest from several private equity firms, according to people familiar with the matter.

Elliott disclosed a 7 percent stake in Mednax last month and said it would discuss several options to boost value for shareholders, including a sale of the company.

Mednax is working with Bank of America Corp (NYSE:BAC) to handle the approaches by Carlyle Group (NASDAQ:CG) LP and other private equity firms, the sources said this week.

Mednax has not yet started the process of selling itself, and there is no certainty any deal will occur, the sources added, requesting anonymity because the discussions are confidential.

"We have not hired an adviser with regards to approaches by private equity firms," a Mednax spokesman said. He would not say whether such overtures had occurred or whether the company had retained Bank of America in any capacity. He also declined to elaborate on the company's plans.

Bank of America and Carlyle declined to comment.

Mednax shares rose as much at 5 percent on the news but were up only 1.2 percent at $50.40 by the afternoon. At that price, the company's market capitalization was around $4.66 billion.

A deal for Mednax would be the latest in a string of acquisitions of physician networks, a business that has struggled in recent years to adapt to changes in how U.S. health insurers reimburse providers.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Federal reimbursement programs such as Medicare and Medicaid, for example, have been trying to shift to a "value-based" payment model, where providers sometimes receive fixed payments to encourage them to control costs.

Last week, Reuters reported that kidney care provider DaVita Inc was exploring a potential sale of its own physician network business, DaVita Medical Group, for up to $4 billion.

Earlier in November, another physician services provider, Envision Healthcare Corp, announced plans to explore strategic alternatives. Previously, it had attracted investments from activist hedge funds Starboard Value and Corvex Management.

Last year, Blackstone (NYSE:BX) Group LP acquired hospital staffing provider Team Health Holdings Inc for $6.1 billion.

Fort Lauderdale, Florida-based Mednax provides neonatal and radiology services through a network of more than 4,075 physicians in all 50 states and Puerto Rico. Its nine-month earnings before interest, taxes, depreciation and amortization have declined to $431 million at the end of September from $493 million a year earlier.

In response, Mednax has announced a series of efforts to boost profits, including a new focus on radiology and a long-term goal to slash general and administrative expenses by around 10 percent.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.